Viewing Study NCT01373333


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-05-26 @ 1:17 AM
Study NCT ID: NCT01373333
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2016-07-20
First Post: 2011-06-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Sponsor:
Organization: